TRAW.NASDAQTraws Pharma, INC

4/A: Traws Pharma COO Corrects Stock Unit Reporting Error in Amended SEC Filing

Sentiment:

SEC Filing Amendment

📋All filings for Traws Pharma, INC
🔒Login to Follow

Nikolay Savchuk, COO of Traws Pharma, files an amended Form 4 to correct a minor error in the reported number of restricted stock units granted.

Summary

  • Nikolay Savchuk, the Chief Operating Officer of Traws Pharma, Inc., filed an amended Form 4 with the SEC on August 7, 2024.
  • This amendment corrects an error in the original Form 4 filed on April 3, 2024, regarding the number of shares underlying a grant of restricted stock units.
  • The original filing incorrectly stated the number of shares as 67,550, while the correct number is 67,500.
  • The amended filing confirms that Savchuk beneficially owns 134,187 shares of Common Stock following the reported transaction.
  • The restricted stock units vest in four equal annual installments starting April 1, 2025, and convert into common stock on a one-for-one basis.

Sentiment

Score: 7

Explanation: The document is a routine correction of a minor error in a regulatory filing, indicating a neutral to slightly positive sentiment due to transparency.

Future Outlook

The restricted stock units will vest in four equal annual installments beginning April 1, 2025.

Industry Context

Form 4 filings are a routine part of insider trading regulations, ensuring transparency in stock ownership changes by company executives and directors.

Key Dates

DateDescription
04/01/2024Date of the transaction involving common stock acquisition.
04/03/2024Date of original Form 4 filing with incorrect information.
04/01/2025First vesting date for the restricted stock units.
08/07/2024Date of amended Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.